loading...| Preferred Name | Azithromycin | |
| Synonyms |
Azithromycin Dihydrate Goxal Zithromax CP-62993 Dihydrate, Azithromycin Toraseptol Azithromycin Monohydrate CP 62993 Azitrocin Monohydrate, Azithromycin CP62993 Zentavion Ultreon Vinzam Sumamed Azythromycin Zitromax 1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-, (2R-(2R*,3S*,4R*,5R*,8R*,10R*,11R*,12S*,13S*,14R*))- Azadose |
|
| Definitions |
A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D017963 |
|
| altLabel |
Azithromycin Dihydrate Goxal Zithromax CP-62993 Dihydrate, Azithromycin Toraseptol Azithromycin Monohydrate CP 62993 Azitrocin Monohydrate, Azithromycin CP62993 Zentavion Ultreon Vinzam Sumamed Azythromycin Zitromax 1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-, (2R-(2R*,3S*,4R*,5R*,8R*,10R*,11R*,12S*,13S*,14R*))- Azadose |
|
| AQL |
AA AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR |
|
| cui |
C0729049 C1257813 C1257814 C1257815 C1257816 C0886592 C0795582 C0678143 C0949528 C0052796 |
|
| DC |
1 |
|
| definition |
A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. |
|
| DX |
19940101 |
|
| HN |
94; was AZITHROMYCIN (NM) 1987-93 |
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000096 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
JTE4MNN1MD 83905-01-5 0 5FD1131I7S |
|
| isa | ||
| LT |
TRD |
|
| Machine permutation |
94; AZITHROMYCIN was indexed under ERYTHROMYCIN/*analogs & derivatives 1987-93 |
|
| Mapped from |
http://purl.bioontology.org/ontology/MESH/C118491 |
|
| MDA |
19930604 |
|
| MMR |
20160701 |
|
| MN |
D02.540.576.500.992.050 |
|
| notation |
D017963 |
|
| OL |
use AZITHROMYCIN (NM) to search AZITHROMYCIN 1987-93 |
|
| PA |
D000900 |
|
| prefLabel |
Azithromycin |
|
| RR |
117772-70-0 (dihydrate) JTE4MNN1MD 121470-24-4 (monohydrate) 5FD1131I7S |
|
| TERMUI |
T527159 T527163 T527169 T527160 T359333 T527167 T053677 T053680 T429892 T053679 T527165 T053678 T527161 T359332 T527162 |
|
| TH |
US NLM (2002) MX UK NL NLM (1999) CA FDA SRS (2014) NLM (1994) ES INN (19XX) DE AU USAN (1987) USP (19XX) BAN (19XX) FR IE |
|
| tui |
T109 T195 |
|
| subClassOf |